Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OM-85 in the Prevention of Respiratory Tract Infections in Children With Wheezing Lower Respiratory Illness
NCT05677763Phase 4Completed
- Sponsor
- OM Pharma
- Start
- Dec 2022
- Primary completion
- Mar 2026
- Modality
- Microbiome Therapeutics, Vaccines & Immunotherapeutics
- Countries
- 6
01
Overview
A Phase 4 trial of OM-85 in respiratory tract infection (RTI), Lower respiratory tract infection (LRTI), sponsored by OM Pharma. Started Dec 2022; status: completed.
02
Drugs
OM-85
03
Conditions
respiratory tract infection (RTI)Lower respiratory tract infection (LRTI)
Beyond the preview
Go deeper on NCT05677763.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05677763.